𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of high-dose cabergoline in Parkinson's disease

✍ Scribed by P. Odin; C. Oehlwein; A. Storch; U. Polzer; G. Werner; R. Renner; M. Shing; A. Ludolph; P. Schüler

Book ID
109337305
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
150 KB
Volume
113
Category
Article
ISSN
0001-6314

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term tolerability and efficacy of c
Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease
✍ R. Inzelberg; P. Nisipeanu; M. J. Rabey; Prof. A. D. Korczyn 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 2 views

## Abstract Motor fluctuations constitute a severe complication of chronic levodopa therapy. The addition of dopamine agonists may partially alleviate these responses; however, due to the short half‐lefe of these drugs, several daily doses are required. Cabergoline is a new dopamine agonist with a

Patient profile, indications, efficacy a
Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease
✍ David Devos 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

## Abstract The studies of duodenal infusion of a levodopa on small groups of parkinsonian patients have reported beneficial effects on motor complications. However, little is known about the patient profile and indications for duodenal levodopa infusion. The purpose of this study is to exhaustivel

Safety and efficacy of perampanel in adv
Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo-controlled study
✍ Karla Eggert; David Squillacote; Paolo Barone; Richard Dodel; Regina Katzenschla 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

Squillacote, received compensation from Eisai for their site's conduct of the study. Drs. Barone, Lees, and Oertel received honoraria from Eisai as members of the Advisory Board of this study. Dr. Rascol has received unrestricted scientific grant and honoraria from Eisai for his advice to the compan